MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer
Giuseppina Roscigno(University of Naples Federico II), Gerolama Condorelli(Institute for Experimental Endocrinology and Oncology)
Cited by 82
Related Papers
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer
|Oncotarget|2017|312
miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
|PLoS ONE|2013|100
PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer Cells
|Cancer Research|2005|59
PED is overexpressed and mediates TRAIL resistance in human non‐small cell lung cancer
|Journal of Cellular and Molecular Medicine|2008|58
Selective inhibition of PED protein expression sensitizes B‐cell chronic lymphocytic leukaemia cells to TRAIL‐induced apoptosis
|International Journal of Cancer|2006|53